Grants per year
- 250 - 275 out of 1,104 results
Search results
-
Research project
SPORE in Breast Cancer: Administration Core
Bulun, S. E., Charness, W., Chatterton Jr, R. T., Clare, S. E., Gradishar, W. J., Khan, S. A., Leikin, R. G., Longnecker, R. M., Rademaker, A. W., Scholtens, D. M., Thimmapaya, B., Weiss, J., Weitzman, S. A. & Wolfman, J.
9/30/00 → 8/31/06
Project: Research project
-
-
-
-
Prot #MORAb-004-203-STS: A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma
Agulnik, M.
Novella Clinical, LLC, Morphotek Inc.
11/19/13 → 11/19/16
Project: Research project
-
Prot #D4190C00011: A Phase 1 Study to Evaluate the Safety, Tolerability, and Efficacy of MEDI4736 in Combination with Tremelimumab or Tremelimumab Alone in Subjects with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Agulnik, M.
PRA Health Sciences, MedImmune, LLC
7/24/15 → 7/24/18
Project: Research project
-
Prot# NU 10B07: Phase II Neoadjuvant Trial with Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
6/15/11 → 6/15/17
Project: Research project
-
-
Prot #CO40016: A Double-Blind, Placebo-Controlled, Randomized Phase III Study Of Ipatasertib In Combination With Paclitaxel As A Treatment For Patients With Pik3ca/Akt1/Pten-Altered, Locally Advanced Or Metastatic, Triple-Negative Breast Cancer Or Hormone
Syneos Health, Inc., Genentech, Inc.
4/19/18 → 4/19/21
Project: Research project
-
Targeting alpha B-Crystallin in Basal-like Breast Cancer
University of Wisconsin-Madison, Breast Cancer Research Foundation
10/1/17 → 9/30/18
Project: Research project
-
AVON Breast Cancer Crusade: Administrative Core
Gradishar, W. J. & Khan, S. A.
Avon Products Foundation, Inc.
3/7/00 → 12/31/06
Project: Research project
-
Prot# IMCL CP20-0903: An Open Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Ramucirumab (IMC-1121B) Drug Product or IMC-18F1 in Combination With Capecitabine or Capecitabine Monotherapy, in Unresectable, Locally Advan
ICON Clinical Research, LLC, ImClone Systems Incorporated
5/27/11 → 5/27/17
Project: Research project
-
-
A Phase I/II Clinical Trial of Cyclosporine A in Patients with Metastatic Breast Cancer
Northwestern Memorial Foundation
9/1/08 → 8/31/13
Project: Research project
-
-
Prot# NU UIC06CC12: An Open Label Phase II Study of Aprepitant for Multi-Day Moderately-High to Highly Emetogenic Chemotherapy Regimens
Agulnik, M.
University of Illinois at Chicago, Merck & Co., Inc.
9/1/07 → 8/31/08
Project: Research project
-
Prot #E7080-G000-604: An Open-Label, Multi-Center, Roll-Over Study to Assess Long Term Safety of Lenvatinib Monotherapy or Lenvatinib Combination Regimen or Comparator Treatment Arm to Cancer Patients in Eisai Sponsored Lenvatinib Trials
Agulnik, M.
PPD Investigator Services, LLC, Eisai, Inc.
2/11/19 → 2/11/22
Project: Research project
-
Prot #AC220-007: A Phase 3 Open-Label Randomized Study of Quizartinib (Ac220) Monotherapy versus Salvage Chemotherapy in Subjects with FLT3-ITD Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed After First-Line Treatment With or Without Hema
Novella Clinical, LLC, Ambit Biosciences Corporation
3/25/14 → 3/25/17
Project: Research project